Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Cough, Dyspnoea, Pulmonary pain, SARS-CoV-2 test
Clinical narrative: anaphylaxis episode; pain near the bottom of his lungs and breathing harder than normal; Coughing; gasping for air/unable to breath from my mouth or nose; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient. A 72-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Sep2021 (Lot number: FE3592) at the age of 72 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: under control; "macular degeneration" (unspecified if ongoing), notes: dry; "Crohn's" (unspecified if ongoing), notes: Crohn's long ago in remission. Concomitant medications included: SIMVASTATIN; LOSARTAN. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL9267, Location of injection: Arm Left), administration date: 10Feb2021, when the patient was 71 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL8982, Location of injection: Arm Left), administration date: 20Jan2021, when the patient was 71 years old, for COVID-19 Immunization. The following information was reported: ANAPHYLACTIC REACTION (medically significant) with onset 01Mar2022 20:30, outcome "unknown", described as "anaphylaxis episode"; PULMONARY PAIN (non-serious) with onset 01Mar2022 20:30, outcome "unknown", described as "pain near the bottom of his lungs and breathing harder than normal"; COUGH (non-serious) with onset 01Mar2022 20:30, outcome "unknown", described as "Coughing"; DYSPNOEA (non-serious) with onset 01Mar2022 20:30, outcome "unknown", described as "gasping for air/unable to breath from my mouth or nose". The events "anaphylaxis episode", "pain near the bottom of his lungs and breathing harder than normal", "coughing" and "gasping for air/unable to breath from my mouth or nose" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (23Nov2021) negative, notes: Covid test type post vaccination=Nasal Swab. Therapeutic measures were taken as a result of anaphylactic reaction, pulmonary pain, cough, dyspnoea. Clinical course details: Last evening (01Mar2022) while attending a hockey game, he ate 3 cashews and 1 pecan. For the first time ever, he immediately started having an anaphylaxis episode. Coughing, gasping for air, unable to breath from his mouth or nose. He kept trying to cough up anything and trying to drink something. After about 3 minutes just before signaling for medical aid, it lessened enough to breath. During intermission, he went to First Aid. They supplied Benadryl. Today (03Mar2022), he still has pain near the bottom of his lungs and breathing harder than normal. He has a doctor appointment on 04Mar2022 to check on it. Never had any allergic reaction before. Just presenting it for your review. He was among the first to receive the first vaccine and also among the first to receive the booster. Hopefully, this does not become a trend. He was concerned about any relationship between a vaccine that raises your immune system to fight COVID, but maybe also raises immune system against nuts. He was the farthest possible from being an anti Vaxer. Additional information: the patient did not have other vaccine in four weeks. The patient did not have covid-19 prior to vaccination. The patient no known allergies until last night.